Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HRMY
RXRX
Add up to 3 more stocks
HRMY
Harmony Biosciences Holdings, Inc.
-1.28%
$39.41-0.51Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$2.28B
52W Range
$25.52 - $43.49
RXRX
Recursion Pharmaceuticals, Inc.
-4.08%
$4.58-0.20Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$2.41B
52W Range
$2.77 - $7.18
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 12.79 | N/A |
| Forward P/E | 10.00 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.28 | 2.63 |
| P/S Ratio | 2.38 | 43.85 |
| P/FCF Ratio | 6.43 | N/A |
| EV/EBITDA | 7.37 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 75.4% | -62.0% |
| Operating Margin | 24.0% | -867.9% |
| Net Margin | 18.9% | -945.9% |
| ROE | 18.1% | -56.7% |
| ROA | 13.2% | -42.8% |
| ROIC | 15.0% | -49.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.48 | 5.03 |
| Quick Ratio | 3.45 | 5.03 |
| Debt/Equity | 0.15 | 0.07 |
| Interest Coverage | 14.23 | -358.08 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.